Quality of Life of Breast Cancer Women During Chemotherapy with Fluorouracil, Doxorubicin and Cyclophosphamide (FAC) Regimen
Objective: To assess quality of life (QoL) of female breast cancer patients undergoing chemotherapy with a fluorouracil, doxorubicin, and cyclophosphamide (FAC) regimen. Material and Methods: This prospective analytical study was performed among 40 Thai female patients receiving the FAC regimen at P...
Main Authors: | Sophit Korpunsilp, Tipaporn Pongmesa |
---|---|
Format: | Article |
Language: | English |
Published: |
Prince of Songkla University
2017-10-01
|
Series: | Journal of Health Science and Medical Research (JHSMR) |
Subjects: | |
Online Access: | https://www.jhsmr.org/index.php/jhsmr/article/view/99 |
Similar Items
-
CHEMOTHERAPY REGIMEN AC (DOXORUBICIN AND CYCLOPHOSPHAMIDE) IN BREAST CANCER – PREVENTION OF NAUSEA AND VOMITING
by: I. A. Koroleva, et al.
Published: (2017-11-01) -
Doxorubicin Is Key for the Cardiotoxicity of FAC (5-Fluorouracil + Adriamycin + Cyclophosphamide) Combination in Differentiated H9c2 Cells
by: Maria Pereira-Oliveira, et al.
Published: (2019-01-01) -
Comparison of Docetaxel, Doxorubicin and Cyclophosphamide (TAC) with 5-Fluorouracil, Doxorubicin and Cyclophosphamide (FAC) Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Phase III Clinical Trial
by: Mohammad Mohammadianpanah, et al.
Published: (2011-04-01) -
Effect of ondansetron alone and in combination with domperidone in the prevention of chemotherapy-induced nausea and vomiting in breast cancer patients
by: Kaberi Das Gupta, A.K.M. Mosharrof Hossain, Saad Uddin Jaigirdar, Borhan Uddin, Tridiv Choudhury and Dipti Rani Saha
Published: (2007-06-01) -
Effects of ondansetron alone and in combination with domperidone in the prevention of chemotherapy-induced nausea and vomiting in breast cancer patients
by: Kaberi Das Gupta, et al.
Published: (2007-06-01)